Mirae Asset Global Investments Co., Ltd. Arcturus Therapeutics Holdings Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 15,073 shares of ARCT stock, worth $325,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,073
Previous 17,569
14.21%
Holding current value
$325,124
Previous $553,000
7.96%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$101 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$59.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$42.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$36.4 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$29.9 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $573M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...